Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 50, Issue 5 , Pages 1161-1171, 1 August 2001

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer☆

Susanne Staar, M.D.
- Department of Radiation Oncology, University of Cologne, Cologne, Germany
- Reprint requests to: Dr. Susanne Staar, Klinik fuer Strahlentherapie der Universitaet zu Koeln, Joseph-Stelzmann-Str. 9, 50933 Koeln, Germany. Tel: +49-221-478 5449; Fax: +49-221-478 6158
Volker Rudat, M.D.
- Department of Radiation Oncology, University of Heidelberg, Heidelberg, Germany
Hartmut Stuetzer, M.D.
- Department of Medical Statistics and Epidemiology, University of Cologne, Cologne, Germany
Andreas Dietz, M.D.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University of Heidelberg, Heidelberg, Germany
Peter Volling, M.D.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University of Oldenburg, Oldenburg, Germany
Michael Schroeder, M.D.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, City Hospital Kassel, Kassel, Germany
Michael Flentje, M.D.
- Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany
Hans Edmund Eckel, M.D.
- Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany
Rolf-Peter Mueller, M.D.
- Department of Radiation Oncology, University of Cologne, Cologne, Germany